We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mycobacteria Use Voltage-Dependent Channels to Prevent Destruction

By LabMedica International staff writers
Posted on 14 Sep 2017
Print article
Image: A photomicrograph of the pathogenic bacterium Mycobacterium avium (Photo courtesy of Wikimedia Commons).
Image: A photomicrograph of the pathogenic bacterium Mycobacterium avium (Photo courtesy of Wikimedia Commons).
A team of molecular microbiologists unraveled the mechanism whereby the pathogenic bacterium Mycobacterium avium modifies the environment inside the macrophage phagosome and transforms it from a killing site to place for growth and reproduction.

M. avium is associated with infection of immunocompromised individuals as well as patients with chronic lung disease. This pathogen infects macrophages and actively interferes with the host killing machinery such as apoptosis and autophagy. The bacteria alter the normal endosomal trafficking, prevent the maturation of phagosomes and modify many signaling pathways inside of the macrophage by secreting effector molecules into the cytoplasm.

Phagosomes are vesicles formed around particles engulfed by phagocytes such as macrophages, neutrophils, and dendritic cells. A phagosome is formed by the fusion of the cell membrane around the microorganism. Phagosomes have membrane-bound proteins to recruit and fuse with lysosomes to form mature phagolysosomes. The lysosomes contain hydrolytic enzymes and reactive oxygen species (ROS), which kill and digest the pathogens Many Mycobacteria, including Mycobacterium tuberculosis and Mycobacterium avium, can manipulate the host macrophage to prevent lysosomes from fusing with phagosomes and creating mature phagolysosomes. Such incomplete maturation of the phagosome maintains an environment favorable to the pathogens inside it.

To identify possible phagosomal proteins that were employed by M. avium to export virulence factors into the cytosol of host cells, investigators at Oregon State University (Corvallis, USA) purified vacuole membrane proteins, and their binding to the surface molecules present in intracellular bacteria was evaluated.

The investigators reported in the August 1, 2017, online edition of the journal Scientific Reports that they had identified voltage-dependent anion channels (VDAC) as components of M. avium vacuoles in macrophages. M. avium mmpL4 proteins were found to bind to VDAC-1 protein. The inactivation of VDAC-1 function either by pharmacological means or siRNA (short inhibiting RNA) led to significant decrease of M. avium survival. Although, they could not establish a role of VDAC channels in the transport of known secreted M. avium proteins, the investigators demonstrated that the porin channels were associated with the export of bacterial cell wall lipids outside of vacuole.

"The idea is to find out the mechanism bacteria use to secrete proteins produced in the cells that have important functions in controlling the phagocytic activity that is supposed to kill them," said senior author Dr. Luiz Bermudez, professor of veterinary medicine at Oregon State University. "A VDAC is very small, but it can become larger if several VDAC proteins get together through polymerization. We found that yes, mycobacteria use surface proteins to bind to the VDAC. But although we tried to see if the proteins of the mycobacterium were exported by the VDAC, we could not show that. However, we did show that another component of the cell wall of the mycobacterium, lipids, are exported by that mechanism."

Related Links:
Oregon State University

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Amoebiasis Test
ELI.H.A Amoeba
New
Unstirred Waterbath
HumAqua 5

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.